Triapex Lab (1938177D CH)

Analysis

Health Care • Hong Kong

Founded in 2008, Triapex Lab (TPL) is a next-generation contract research organization (CRO) dedicated to empowering pharmaceutical enterprises and research institutions worldwide. Its approach centers on clinically significant disease areas, including cardiometabolic diseases, central nervous system (CNS) disorders, ophthalmology, autoimmune diseases, and oncology.

Refresh

No filings found

We’ll display filings we find for Triapex Lab here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00